Oseltamivir and the influenza alphabet

Clinical Infectious Diseases

Volumn 43, Issue 4, 2006, Pages 445-446

  Baum, Stephen G ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; OSELTAMIVIR; RIMANTADINE; ZANAMIVIR;

CLINICAL FEATURE; DISEASE DURATION; DRUG EFFICACY; FEVER; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFECTION PREVENTION; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MORTALITY; NONHUMAN; NOTE; PRIORITY JOURNAL; VIRUS ISOLATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ACETAMIDES; ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; OSELTAMIVIR;

EID: 33746612378     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/505873     Document Type: Note

References (1)

1. Kawai N, Ikematsu H, Iwaki N, et al. A Comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese, multicenter study of the 2003-2004 and 2004-2005 influenza seasons. Clin Infect Dis 2006; 43:439-44 (in this issue).